In non-dialyzed CKD patients, evidence about PON1 activity seems to be controversial, not only due to diverse substrates employed to measure PON1 activity, but also due to different stages of CKD selected in each study and to dissimilarities in the percentage of subjects under statin therapy. This evidence concerns the gene PON1 and chronic kidney disease.